Antibody data
- Product number
- PA5-76559
- Provider
- Invitrogen Antibodies
- Product name
- SLC22A12 Polyclonal Antibody
- Provider product page
- Invitrogen Antibodies - PA5-76559
- Antibody type
- Polyclonal
- Antigen
- Recombinant full-length protein
- Description
- For reconstitution, we recommend adding 100 µL distilled water to a final antibody concentration of about 1 mg/mL. To use this carrier-free antibody for conjugation experiments, we strongly recommend performing another round of desalting. (Zeba Spin Desalting Columns, 7KMWCO, 0.5 mL, Product # 89882)
- Reactivity
- Human, Mouse, Rat
- Host
- Rabbit
- Isotype
- IgG
- Vial size
- 100 µL
- Concentration
- 1 mg/mL
- Storage
- Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles.
Supportive validation
- Submitted by
-
Invitrogen Antibodies (provider)
- Main image

- Experimental details
- Western blot analysis of SLC22A12 in extracts of HepG2 cell line. Samples were incubated with SLC22A12 polyclonal antibody (Product # PA5-76559).
Supportive validation
- Submitted by
-
Invitrogen Antibodies (provider)
- Main image

- Experimental details
- Western blot analysis of SLC22A12 in extracts of HepG2 cell line. Samples were incubated with SLC22A12 polyclonal antibody (Product # PA5-76559).
Supportive validation
- Submitted by
-
Invitrogen Antibodies (provider)
- Main image

- Experimental details
- 5 FIGURE Effects of Yi-Suan-Cha on the protein levels of renal transporters. Proteins were extracted from the kidney for Western blot analysis of URAT1 (A, B), ABCG2 (A, C), OAT1 (A, D), and GLUT9 (A, E). * p < 0.05 compared to the normal control; # p < 0.05 compared to the hyperuricemia control. Con., control; YC-L, low-dose Yi-Suan-Cha; YC-H, high-dose Yi-Suan-Cha
Supportive validation
- Submitted by
-
Invitrogen Antibodies (provider)
- Main image

- Experimental details
- FIGURE 5 Effects of Yi-Suan-Cha on the protein levels of renal transporters. Proteins were extracted from the kidney for Western blot analysis of URAT1 (A, B), ABCG2 (A, C), OAT1 (A, D), and GLUT9 (A, E). * p < 0.05 compared to the normal control; # p < 0.05 compared to the hyperuricemia control. Con., control; YC-L, low-dose Yi-Suan-Cha; YC-H, high-dose Yi-Suan-Cha